E-LIB Suche - Ergebnisse für: Egan, Jack O

1

A novel interleukin-2-based fusion molecule, HCW9302, diffe..:

Zhu, Xiaoyun ; Li, Qiongzhen ; George, Varghese...
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

2

Immunotherapeutic approach to reduce senescent cells and al..:

Shrestha, Niraj ; Chaturvedi, Pallavi ; Zhu, Xiaoyun...
Aging Cell. 22 (2023) 5 - p. , 2023

Link: https://doi.org/10.1111/..

3

Bifunctional TGF-β trap/IL-15 protein complex elicits poten..:

Liu, Bai ; Zhu, Xiaoyun ; Kong, Lin...
Molecular Therapy. 29 (2021) 10 - p. 2949-2962 , 2021

Link: https://doi.org/10.1016/..

4

Intravesical ALT-803 and BCG Treatment Reduces Tumor Burden..:

Gomes-Giacoia, Evan ; Miyake, Makito ; Goodison, Steve...
PLoS ONE. 9 (2014) 6 - p. e96705 , 2014

Link: https://doi.org/10.1371/..

5

The effect of Arg306 → Ala and Arg506 → Gln substitutions i..:

Egan, Jack O. ; Kalafatis, Michael ; Mann, Kenneth G.
Protein Science. 6 (1997) 9 - p. 2016-2027 , 1997

Link: https://doi.org/10.1002/..

6

Hepatitis B virus DNA integration and expression of an erb ..:

Zhang, Xiao-Kun ; Egan, Jack O. ; Huang, Dao-pei...
Biochemical and Biophysical Research Communications. 188 (1992) 1 - p. 344-351 , 1992

Link: https://doi.org/10.1016/..

7

Immunotherapeutic approach to reduce senescent cells and al..:

Shrestha, Niraj ; Chaturvedi, Pallavi ; Zhu, Xiaoyun...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186597/. , 2023

Link: http://www.ncbi.nlm.nih...

8

A novel interleukin-2-based fusion molecule, HCW9302, diffe..:

Zhu, Xiaoyun ; Li, Qiongzhen ; George, Varghese...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907325/. , 2023

Link: http://www.ncbi.nlm.nih...

9

Bifunctional TGF-β trap/IL-15 protein complex elicits poten..:

Liu, Bai ; Zhu, Xiaoyun ; Kong, Lin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531151/. , 2021

Link: http://www.ncbi.nlm.nih...

10

A fusion protein complex that combines IL12, IL15, and IL18..:

Becker-Hapak, Michelle K ; Shrestha, Niraj ; McClain, Ethan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416787/. , 2021

Link: http://www.ncbi.nlm.nih...

11

First-in-human phase 1 clinical study of the IL-15 superago..:

Romee, Rizwan ; Cooley, Sarah ; Berrien-Elliott, Melissa M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992862/. , 2018

Link: http://www.ncbi.nlm.nih...

12

ALT-803 Transiently Reduces Simian Immunodeficiency Virus R..:

Ellis-Connell, Amy L ; Balgeman, Alexis J ; Zarbock, Katie R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774892/. , 2018

Link: http://www.ncbi.nlm.nih...

13

PHASE I TRIAL OF ALT-803, A NOVEL RECOMBINANT INTERLEUKIN-1..:

Margolin, Kim ; Morishima, Chihiro ; Velcheti, Vamsidhar...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239933/. , 2018

Link: http://www.ncbi.nlm.nih...

14

ALT-803, an IL-15 superagonist, in combination with nivolum..:

Wrangle, John M ; Velcheti, Vamsidhar ; Patel, Manish R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089612/. , 2018

Link: http://www.ncbi.nlm.nih...

15

Comparison of the super agonist complex, ALT-803, to IL-15 ..:

Rhode, Peter R ; Egan, Jack O ; Xu, Wenxin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703482/. , 2015

Link: http://www.ncbi.nlm.nih...